NFKB1 and inflammatory bowel disease: Although the in vitro effects of resveratrol on intestinal inflammation are contradictory [70], animal studies have shown that resveratrol can reduce the severity of intestinal inflammation in IBD models by downregulating several intestinal immunity mediators and affecting key components of the inflammatory cascade, mainly the inhibition of NF-κB activation and the attenuation of reactive species production [73].